Multidisciplinary Thoracic Cancers Symposium - 2017

March 16-18, 2017
San Francisco Marriot Marquis

The 2017 Multidisciplinary Thoracic Cancer Symposium is a two-and-a-half day meeting featuring interactive case discussions; educational sessions on new multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current early phase clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation and surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, the attendees will be updated on the appropriate integration of all the advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention and management of common toxicities.

Target Audience

This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pulmonologists and pathologists. 

Learning Objectives

Upon completion of this live activity, attendees should be able to do the following:

  • Discuss the relevance of the precision medicine initiative for clinical practice in thoracic malignancies.
  • Explain the appropriate integration of targeted and immunotherapy in the daily clinical management of thoracic malignancies.
  • Explain the application and limitations of advanced radiation and surgical techniques in thoracic malignancies.
Course summary
Available credit: 
  • 19.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 19.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 19.00 Certificate of Attendance
    This activity was designated for 19.00 AMA PRA Category 1 Credit™.
Course opens: 
05/16/2017
Course expires: 
03/18/2024
Cost:
$0.00
Rating: 
0

Physicians

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ASTRO designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 19.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 19.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 19.00 Certificate of Attendance
    This activity was designated for 19.00 AMA PRA Category 1 Credit™.

Accreditation Period

Course opens: 
05/16/2017
Course expires: 
03/18/2024

Price

Cost:
$0.00
Please login or register to take this course.